Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?

Breast

Volumn 15, Issue 2, 2006, Pages 167-172

  Burge, Chandra N ^a   Chang, Helena R ^a   Apple, Sophia K ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Breast cancer; Estrogen; Her2 neu; p53; Progesterone

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; KI 67 ANTIGEN; PROGESTERONE RECEPTOR; PROTEIN BCL 2; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; BREAST SURGERY; CANCER GRADING; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCORING SYSTEM; BIOPSY; BREAST TUMOR; CANCER STAGING; EVALUATION; MEDICAL RECORD; METABOLISM; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; STANDARD;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MEDICAL RECORDS; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 33746298407     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.breast.2005.06.004     Document Type: Article

References (16)

1. American Cancer Society. Website: www.cancer.org.
2. Connor C.S., Tawfik O.W., Joyce A.J., Davis M.K., Mayo M.S., and Jewell W.R. A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimens. Am J Surg 184 (2002) 322-324
3. Jacobs T.W., Siziopikou K.P., Drioleau J.E., et al. Do prognostic marker studies on core needle biopsies of breast carcinoma accurately reflect the marker status of the tumor. Mod Pathol 11 (1998) 259-264
4. Meyer J.S., Schechtman K., and Valdes Jr. R. Estrogen and progesterone receptor assays on breast carcinoma from mastectomy specimens. Cancer 52 (1983) 2139-2143
5. Sharifi S., Peterson M.K., Baum J.K., Raza S., and Schnitt S.J. Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol 12 (1999) 941-945
6. Zidan A., Christie Brown J.S., Peston D., and Shousha S. Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma. J Clin Pathol 50 (1997) 27-29
7. Douglas-Jones A.G., Collett N., Morgan J.M., and Jasani B. Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinoma. J Clin Pathol 54 (2001) 951-953
8. Elston C.W., and Ellis I.O. Pathological prognostic factors in breast cancer: the value of histologic grade in breast cancer and experience from a large study with long-term follow-up. Histopathology 19 (1991) 403-410
9. Harris G.C., Denley H.E., Pinder S.E., et al. Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol 27 (2003) 11-15
10. Hoda S.A., Harigopal M., Harris G.C., Pinder S.E., Lee A.H., and Ellis I.O. Expert opinion: reporting needle core biopsies of breast carcinomas. Histopathology 43 (2003) 84-90
11. Taucher S., Rudas M., Mader R.M., et al. Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klin Wochenschr 116 (2004) 26-31
12. Mueller-Holzner E., Fink V., Frede T., and Marth C. Immunohistochemical determination of Her2 expression in breast cancer from core biopsy specimens: a reliable predictor of Her2 status of the whole tumor. Breast Cancer Res Treat 69 (2001) 13-19
13. Hubbard A.L., Doris C.P., Thompson A.M., Chetty U., and Anderson T.J. Critical determination of the frequency of c-erbB-2 amplification in breast cancer. Brit J Cancer 70 (1994) 434-439
14. Slamon D.J., Clark G.M., Wong S.G., Levin W.J., Ullrich A., and McGuire W.L. Human breast cancer: correlation of relapse and survival with amplification of the Her-2/neu oncogene. Science 235 (1987) 177-182
15. Berger M.S., Locher G.W., Saurer S., et al. Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res 48 (1988) 1238-1243
16. Zeillinger R., Kury F., Czerwenka K., et al. Her-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer. Oncogene 4 (1989) 109-114